The Current and Future Burden of Long COVID in the United States (U.S.).

Publication date: Jan 22, 2025

Long COVID, which affects an estimated 44. 69-48. 04 million people in the U. S., is an ongoing public health concern that will continue to grow as SARS-CoV-2 continues to spread. We developed a computational simulation model representing the clinical course, the health effects, and the associated costs of a person with Long COVID. Simulations show that the average total cost of a Long COVID case can range from $5,084-$11,646 (assuming symptoms only last 1 year) with 92. 5%-95. 2% of these costs being productivity losses. Therefore, the current number of Long COVID cases could end up costing society at least $2. 01-$6. 56 billion, employers at least $1. 99-$6. 49 billion in productivity losses, and third-party payers $21-68. 5 million annually (6%-20% probability of developing Long COVID). These cases would accrue 35,808-121,259 QALYs lost and 13,484-45,468 DALYs. Moreover, each year, there may be an additional $698. 5 million in total costs, 14,685 QALYs lost, and 5,628 DALYs, if the incidence of COVID is 100 per 10,000 persons (similar to that seen in 2023). Every 10-point increase in COVID incidence results in an additional $365 million in total costs, 5,070 QALYs lost, and 1,900 DALYs each year. The current health and economic burden of Long COVID may already exceed that of a number of other chronic disease and will continue to grow each year as there are more and more COVID-19 cases. This could be a significant drain on businesses, third party payers, the healthcare system, and all of society.

Concepts Keywords
Businesses Cost
Party Disability-adjusted Life Years
Economic
Long COVID
Long-haul COVID
Model
Post-COVID Conditions
Quality-adjusted Life Years

Semantics

Type Source Name
disease MESH Long COVID
disease MESH clinical course
disease MESH chronic disease
disease MESH COVID-19
disease MESH sequelae
disease IDO quality

Original Article

(Visited 2 times, 1 visits today)